PRESS RELEASE NORTH CHICAGO, Ill.,Might 26, 2015/PRNewswire/ –AbbVie , a worldwide biopharmaceutical company, announced today that it has completed the acquisition of Pharmacyclics, Inc. Enhancing AbbVie's scientific and commercial existence in oncology. Pharmacyclics is a leader in the hematological oncology market with Imbruvica® , a first-in-class BTK-inhibitor used to treat hematological cancers, a$24 billionglobal market.Past conferences have been kept in Sydney, Vancouver and London, among others. Sir David Nicholson, who stepped down March 31 as chief executive officer of England's National Health Provider, the world's largest publicly funded healthcare system, gives the keynote address, providing his take on interprofessional care from both the supplier and payer perspectives. Steven Shapiro, M.D., UPMC's chief scientific and medical officer; Mark A. Wagner, M.D., executive dean of education at Mayo Clinic; and Barbara Brandt, Ph.D., director of the National Middle for Interprofessional Practice and Education at the University of Minnesota, gives the opening plenary program on advancing interprofessionalism in the U.S. Related StoriesReducing medical center readmissions through Transitional Care: an interview with Rani KhetarpalThe Royal College of Surgeons Edinburgh endorses Contact Surgery, a cellular cognitive simulation and rehearsal platform for surgeonsNHS ‘hourglass’ framework holds back development of support workforce Pitt and UPMC were recently chosen as a joint advancement incubator site for the National Middle for Interprofessional Education and Collaborative Practice.